|
Marknaden stängd -
Andra börsplatser
|
Efter stängning 20.30.48 | |||
| 9,646 EUR | +1,92 % |
|
9,649 | +0,03 % |
| 04-16 | Grifols erhåller FDA-godkännande för screeningtest av malaria i blod | RE |
| 04-15 | Europeiska ADR-noteringar backar i den amerikanska handeln på onsdagen | MT |
Officiella publikationer
| 02-26 | Annual Report | CO |
| 02-26 | Annual Report | CO |
| 02-26 | Integrated report | CO |
| 02-26 | Integrated report | CO |
| 02-26 | Annual financial report | CO |
| 02-26 | Annual financial report | CO |
| 02-26 | Slide show results | CO |
| 02-26 | Slide show results | CO |
| 02-26 | Annual results | CO |
| 02-26 | Annual results | CO |
| 11-04 | Slide show Q3 | CO |
| 11-04 | Slide show Q3 | CO |
| 11-04 | 3rd quarter results | CO |
| 11-04 | 3rd quarter results | CO |
| 2025-07-29 | Slide show half-year results | CO |
| 2025-07-29 | Slide show half-year results | CO |
| 2025-07-29 | Half-year report | CO |
| 2025-07-29 | Half-year report | CO |
| 2025-07-29 | 1st-half-year results | CO |
| 2025-07-29 | 1st-half-year results | CO |
| 2025-05-12 | Slide show Q1 | CO |
| 2025-05-12 | Slide show Q1 | CO |
| 2025-05-12 | 1st quarter results | CO |
| 2025-05-12 | 1st quarter results | CO |
| 2025-03-31 | Public takeover bid | CO |
- Börsen
- Aktier
- GRF Aktie
- Nyheter Grifols, S.A.
- Officiella publikationer
Välj din utgåva
All finansiell information anpassad till den nationella nivån
MarketScreener is also available in this country: United States.
Switch edition
Stanna i nuvarande landsutgåva